Literature DB >> 28275466

Surgery in microscopically pathological N2 non-small cell lung cancer: the size of lymph node matters.

Ming-Ching Lee1, Chung-Ping Hsu1.   

Abstract

Entities:  

Year:  2017        PMID： 28275466      PMCID： PMC5334087          DOI： 10.21037/jtd.2017.02.46

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

Review 1.  What to do with "Surprise" N2?: intraoperative management of patients with non-small cell lung cancer.

Authors:  Frank Detterbeck
Journal:  J Thorac Oncol       Date:  2008-03       Impact factor: 15.609

2.  Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.

Authors:  Elena Garelli; Stéphane Renaud; Pierre-Emmanuel Falcoz; Noëlle Weingertner; Anne Olland; Nicola Santelmo; Gilbert Massard
Journal:  Eur J Cardiothorac Surg       Date:  2016-02-25       Impact factor: 4.191

3.  Stage IIIA category of non-small-cell lung cancer: a new proposal.

Authors:  M R Green; R C Lilenbaum
Journal:  J Natl Cancer Inst       Date:  1994-04-20       Impact factor: 13.506

4.  Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.

Authors:  F Andre; D Grunenwald; J P Pignon; A Dujon; J L Pujol; P Y Brichon; L Brouchet; E Quoix; V Westeel; T Le Chevalier
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

5.  Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer.

Authors:  Stephen A Barnett; Robert J Downey; Junting Zheng; Gabriel Plourde; Ronglai Shen; Jamie Chaft; Timothy Akhurst; Bernard J Park; Valerie W Rusch
Journal:  Ann Thorac Surg       Date:  2016-01-12       Impact factor: 4.330

Review 6.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Authors:  Hisao Asamura; Kari Chansky; John Crowley; Peter Goldstraw; Valerie W Rusch; Johan F Vansteenkiste; Hirokazu Watanabe; Yi-Long Wu; Marcin Zielinski; David Ball; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

7.  Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.

Authors:  Christophe Dooms; Eric Verbeken; Sigrid Stroobants; Kris Nackaerts; Paul De Leyn; Johan Vansteenkiste
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.